Investments
5Partners & Customers
10About Japan Tobacco
Japan Tobacco is an international tobacco product company. Its products are sold in over 120 countries and its internationally recognized brands include Winston, Camel, Mevius and Benson & Hedges. With diversified operations, JT is also actively present in pharmaceuticals, beverages and processed foods.
Japan Tobacco Headquarter Location
2-1, Toranomon 2-chome Minato-ku
Tokyo, 105-8422,
Japan
+81-3-3582-3111
Japan Tobacco Web Traffic
Japan Tobacco Rank
Latest Japan Tobacco News
Apr 29, 2022
The market leader in Russia, JT has four factories and 4,000 employees in the country. The post Japan Tobacco Considers Sale of Russian Operations appeared first on Tobacco Reporter.
Japan Tobacco Investments
5 Investments
Japan Tobacco has made 5 investments. Their latest investment was in Tokyo eSports Gate as part of their Series A on October 10, 2021.
Japan Tobacco Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
10/27/2021 | Series A | Tokyo eSports Gate | $2.64M | Yes | Gushcloud International Ventures, Media Create Communications, PROPERTY AGENT, Robot Home, and Undisclosed Investors | 3 |
10/21/2019 | Series A - III | |||||
3/31/2017 | Series A | |||||
7/15/2016 | Corporate Minority | |||||
2/17/2016 | Corporate Minority |
Date | 10/27/2021 | 10/21/2019 | 3/31/2017 | 7/15/2016 | 2/17/2016 |
|---|---|---|---|---|---|
Round | Series A | Series A - III | Series A | Corporate Minority | Corporate Minority |
Company | Tokyo eSports Gate | ||||
Amount | $2.64M | ||||
New? | Yes | ||||
Co-Investors | Gushcloud International Ventures, Media Create Communications, PROPERTY AGENT, Robot Home, and Undisclosed Investors | ||||
Sources | 3 |
Japan Tobacco Acquisitions
13 Acquisitions
Japan Tobacco acquired 13 companies. Their latest acquisition was Akij Group - Tobacco Business on August 06, 2018.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
8/6/2018 | Acquired Unit | 2 | ||||
3/16/2018 | Acquired | 1 | ||||
12/21/2017 | Other | $510M | Acquired | 1 | ||
8/22/2017 | ||||||
8/4/2017 |
Date | 8/6/2018 | 3/16/2018 | 12/21/2017 | 8/22/2017 | 8/4/2017 |
|---|---|---|---|---|---|
Investment Stage | Other | ||||
Companies | |||||
Valuation | |||||
Total Funding | $510M | ||||
Note | Acquired Unit | Acquired | Acquired | ||
Sources | 2 | 1 | 1 |
Japan Tobacco Partners & Customers
10 Partners and customers
Japan Tobacco has 10 strategic partners and customers. Japan Tobacco recently partnered with Orphagen Pharmaceuticals on June 6, 2018.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
6/1/2018 | Partner | United States | `` We have had a long and successful history with the pharmaceutical division of Japan Tobacco Inc. and I am delighted to be able to expand our relationship with this leading organization , '' said Scott Thacher , Orphagen Pharmaceuticals 's President and CEO . | 1 | |
10/12/2017 | Licensor | Ireland | Opko Health Inks $118 Million Deal with Japan Tobacco, Inc. for Rayaldee `` Japan Tobacco Inc. , together with its subsidiary Torii Pharmaceuticals , has a strong and growing franchise in hemodialysis and renal diseases , which makes Japan Tobacco Inc. an ideal partner to bring RAYALDEE to physicians and patients in Japan , '' said Phillip Frost , M.D. , Chairman and Chief Executive Officer of OPKO Health , Inc. . | 2 | |
10/12/2017 | Licensor | United States | Opko Health Inks $118 Million Deal with Japan Tobacco, Inc. for Rayaldee `` Japan Tobacco Inc. , together with its subsidiary Torii Pharmaceuticals , has a strong and growing franchise in hemodialysis and renal diseases , which makes Japan Tobacco Inc. an ideal partner to bring RAYALDEE to physicians and patients in Japan , '' said Phillip Frost , M.D. , Chairman and Chief Executive Officer of OPKO Health , Inc. . | 4 | |
8/10/2016 | Licensor, and Licensee | ||||
1/20/2016 | Vendor |
Date | 6/1/2018 | 10/12/2017 | 10/12/2017 | 8/10/2016 | 1/20/2016 |
|---|---|---|---|---|---|
Type | Partner | Licensor | Licensor | Licensor, and Licensee | Vendor |
Business Partner | |||||
Country | United States | Ireland | United States | ||
News Snippet | `` We have had a long and successful history with the pharmaceutical division of Japan Tobacco Inc. and I am delighted to be able to expand our relationship with this leading organization , '' said Scott Thacher , Orphagen Pharmaceuticals 's President and CEO . | Opko Health Inks $118 Million Deal with Japan Tobacco, Inc. for Rayaldee `` Japan Tobacco Inc. , together with its subsidiary Torii Pharmaceuticals , has a strong and growing franchise in hemodialysis and renal diseases , which makes Japan Tobacco Inc. an ideal partner to bring RAYALDEE to physicians and patients in Japan , '' said Phillip Frost , M.D. , Chairman and Chief Executive Officer of OPKO Health , Inc. . | Opko Health Inks $118 Million Deal with Japan Tobacco, Inc. for Rayaldee `` Japan Tobacco Inc. , together with its subsidiary Torii Pharmaceuticals , has a strong and growing franchise in hemodialysis and renal diseases , which makes Japan Tobacco Inc. an ideal partner to bring RAYALDEE to physicians and patients in Japan , '' said Phillip Frost , M.D. , Chairman and Chief Executive Officer of OPKO Health , Inc. . | ||
Sources | 1 | 2 | 4 |
Japan Tobacco Team
1 Team Member
Japan Tobacco has 1 team member, including current Chief Executive Officer, President, Mitsuomi Koizumi.
Name | Work History | Title | Status |
|---|---|---|---|
Mitsuomi Koizumi | Chief Executive Officer, President | Current |
Name | Mitsuomi Koizumi |
|---|---|
Work History | |
Title | Chief Executive Officer, President |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.